Nanotechnology Databases

Comprehensive databases for nanomaterials, events, products,
companies, research labs, degree programs and publications

 

Nanobiotechnology and Nanomedicine Companies

 

(Links listed alphabetically)

 
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | All
 

Showing results 126 - 150 of 295

 
The company's targeted nanocapsule technology is designed using a flexible formulation process and can carry large or small molecules, custom target delivery to different organs, tissues and cells, and be applied several ways including topically, intravenously, or via devices or tablets.
The company is developing therapeutic immunotherapy by incorporating virus-specific immunogenic DNA into nanoparticles.
Genetix is an independent business unit within Leica Microsystems. The company provides scientists and clinicians with unrivalled solutions for imaging and intelligent image analysis in the life science and clinical markets.
Genovis has a broad knowledge within physics, biology and biochemistry and offers nanoparticles as tools in medical imaging and for in vitro/in vivo transfections. We have developed a new category of nanoparticles that generate a contrast effect in more than one type of medical imaging technique and offer customer made nanoparticles which besides the particles per se also include method development and services in the form of pre-studies that are specifically adapted to the individual needs of the customer.
Genovoxx is developing a technology for the massively parallel sequencing by synthesis of nucleic acids. This technology enables the sequencing of many millions of nucleic acids molecules in parallel format at the single molecule level.
One of the world's foremost biotechnology companies, the company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, transplant, cancer, and diagnostic testing.
The company applies nanoscale solid phase organic synthesis in the preparation of its high density chemical microarrays for drug discovery.
iCeutica has developed the Encapsulated Organic Nanoparticles (EON™) Platform to produce consistent nano-sized drug particles.
(German language site) The company is a Contract Research Organisation for the development and improvement of advanced cell culture systems for industrial drug screening applications, biomaterial testing and pharma-toxicological research.
A spin off founded to commercialize FDEC FET nano sensor technology invented at Arizona State University.The novel nano sensor technology is capable of exponential capacitive transduction for ultra high sensitivity molecular detection, coupled with exceptional selectivity.
Inanovate creates nano-scale surface structures through a unique and proprietary process capable of nano-meter precision in a time and cost effective way. Leveraging this unique platform and expertise, Inanovate is developing nano-structured biochip substrates to facilitate the next generation in biochip technology.
The company has active internal drug discovery programs focused on the identification of novel small molecule drugs for oncology, inflammation, HIV and diabetes.
Offers different microfluidic platforms that precisely manipulate different combinations of fluids to obtain jets, emulsions, bubbles, drops and particles in the nano and micrometric range.
The company's lead product in development is Amorphous Nano-Hydroxyapaite Powder. Nano-structured hydroxyapatite has several advantages over hydroxyapatite of larger particle size in its use in bone tissue engineering due to its higher surface area and consequently higher reactivity, which offers better cellular response. In addition, nano-sized hydroxyapatite is useful as an effective surface modification agent for binding numerous biological molecules.
The foundation of the company's IVEC™ drug delivery platform is based on polymer micelle technology, spherical nanosized capsules formed by the assembly of block copolymers in water.
Develops a nanoparticle-based siRNA targeting the VEGF (Vascular Endothelial Growth Factor) pathwayas part of its RNA interference (RNAi) therapeutics for the treatment of human diseases.
Develops and markets a nanoparticle vector technology that combines DNA with the lipids DOTAP and cholesterol to create a synthetic gene delivery vehicle.
Molecular probes and nano conjugates.
Iris Biotechnologies is dedicated to the development of Nano-Biochip gene expression kits to assist in establishing a solid and reliable foundation for personalized medicine. The company's patented products were developed to overcome the sensitivity, specificity, speed and cost limitations of present state-of-the-art microarray technology.
The company specializes in providing protein engineering to pharmaceutical and biotechnology companies for the discovery, identification and design of new peptide, polypeptide, protein and antibody compounds using their proprietary technology.
Develops scientific instrumentation and software for biomolecular and cellular bio applications including submicron analytical devices.
Primary goals of the company are the development and the establishment of innovative bioinstrumentation based on Femtosecond Laser Technology for biotechnology, cell biology and medicine, e.g. nanoprocessing with femtosecond near infrared laser pulses.
Develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease.
Keystone Nano has an exclusive license to Penn State patented technology that allows the creation of stable, non-toxic, 5 to 50 nm-composite particles that they call Molecular Dots (MDs). These Molecular Dots can encapsulate drugs and/or fluorescent molecules.
Develops and manufactures acoustic droplet ejection (ADE) systems, a fully automated, non-contact, nozzle-free technology to dispense nanoliters of liquids.
 
 
 
left arrowBack to Nanotechnology Links Directory